Kueht M, Jindra P, Stevenson H, Galvan T, Murthy B, Goss J
Mol Genet Metab Rep. 2021; 26:100705.
PMID: 33489761
PMC: 7811052.
DOI: 10.1016/j.ymgmr.2020.100705.
Legaz I, Boix F, Lopez M, Alfaro R, Galian J, Llorente S
J Clin Med. 2020; 9(3).
PMID: 32151032
PMC: 7141359.
DOI: 10.3390/jcm9030708.
Nguyen A, Lourenco L, Chung B, Imamura T, Rodgers D, Besser S
J Heart Lung Transplant. 2018; 37(11):1322-1328.
PMID: 30174163
PMC: 6289951.
DOI: 10.1016/j.healun.2018.06.009.
Tokodai K, Miyagi S, Nakanishi C, Hara Y, Nakanishi W, Goto M
Transplant Direct. 2017; 3(8):e196.
PMID: 28795147
PMC: 5540634.
DOI: 10.1097/TXD.0000000000000713.
Key T, Watson C, Clatworthy M, ORourke C, Goodman R, Taylor C
NDT Plus. 2015; 3(6):579-81.
PMID: 25949473
PMC: 4421431.
DOI: 10.1093/ndtplus/sfq160.
Human hepatic stellate cells inhibit T-cell response through B7-H1 pathway.
Charles R, Chou H, Wang L, Fung J, Lu L, Qian S
Transplantation. 2013; 96(1):17-24.
PMID: 23756770
PMC: 3696433.
DOI: 10.1097/TP.0b013e318294caae.
The effect of a positive T-lymphocytotoxic crossmatch on clinical outcomes in adult-to-adult living donor liver transplantation.
Kim Y, Kim S, Moon I, Han S, Cho S, You T
J Korean Surg Soc. 2013; 84(4):245-51.
PMID: 23577320
PMC: 3616279.
DOI: 10.4174/jkss.2013.84.4.245.
Evidence for hyperacute rejection of human liver grafts: The case of the canary kidneys.
Starzl T, Demetris A, Todo S, Kang Y, Tzakis A, Duquesnoy R
Clin Transplant. 2010; 3:37-45.
PMID: 21151799
PMC: 3000169.
Factors in the Development of Liver Transplantation.
Starzl T, Iwatsuki S, Shaw B, Gordon R, Esquivel C, Todo S
Transplant Proc. 2010; 17(Suppl 2):107-119.
PMID: 20634921
PMC: 2903836.
Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch.
Doyle H, Marino I, Morelli F, Doria C, Aldrighetti L, McMichael J
Ann Surg. 1996; 224(2):168-77.
PMID: 8757380
PMC: 1235338.
DOI: 10.1097/00000658-199608000-00009.
Humoral rejection associated with antidonor lymphocytotoxic antibodies following liver transplantation.
Manez R, Kobayashi M, Takaya S, Bronsther O, Kramer D, Bonet H
Transplant Proc. 1993; 25(1 Pt 2):888-90.
PMID: 8442258
PMC: 2967757.
Induction of T-cell hyporesponsiveness by intrahepatic modulation of donor antigen-presenting cells.
Chung S, Gorczynski R, Dziadkowiec I, Levy G
Immunology. 1995; 85(4):582-90.
PMID: 7558153
PMC: 1383787.
Positive, warm T cell crossmatch in cardiac transplantation: with transient vasculitis and without hyperacute rejection.
Singh G, Rabin B, Thompson M, Hardesty R, Griffith B, Bahnson H
Transplantation. 1982; 33(5):564-6.
PMID: 7046169
PMC: 2976668.
DOI: 10.1097/00007890-198205000-00023.
Evolution of liver transplantation.
Starzl T, Iwatsuki S, Van Thiel D, Gartner J, Zitelli B, Malatack J
Hepatology. 1982; 2(5):614-36.
PMID: 6749635
PMC: 2972731.
DOI: 10.1002/hep.1840020516.
Liver transplantation against T cell-positive warm crossmatches.
Iwatsuki S, Rabin B, Shaw Jr B, Starzl T
Transplant Proc. 1984; 16(6):1427-9.
PMID: 6390842
PMC: 2846545.
Hepatic transplantation and biliary atresia: early experience in eight patients.
Ascher N, Najarian J
World J Surg. 1984; 8(1):57-63.
PMID: 6367234
DOI: 10.1007/BF01658364.
Liver transplantation.
West J Med. 1983; 139(4):507-14.
PMID: 6359713
PMC: 1021558.
Current status of hepatic transplantation.
Iwatsuki S, Shaw Jr B, Starzl T
Semin Liver Dis. 1983; 3(3):173-80.
PMID: 6353593
PMC: 2956487.
DOI: 10.1055/s-2008-1040683.
Immunosuppression and other nonsurgical factors in the improved results of liver transplantation.
Starzl T, Iwatsuki S, Shaw Jr B, Gordon R, Esquivel C
Semin Liver Dis. 1985; 5(4):334-43.
PMID: 3909427
PMC: 2975458.
DOI: 10.1055/s-2008-1040630.
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection.
Fung J, Demetris A, Porter K, Iwatsuki S, Gordon R, Esquivel C
Nephron. 1987; 46 Suppl 1:19-33.
PMID: 3306422
PMC: 2994552.
DOI: 10.1159/000184431.
